NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
UBS Group AG | 105 | $0 | 0.00% |
Parallel Advisors, LLC | 350 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |